<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03340454</url>
  </required_header>
  <id_info>
    <org_study_id>17-01446</org_study_id>
    <secondary_id>2U54MD000538</secondary_id>
    <nct_id>NCT03340454</nct_id>
  </id_info>
  <brief_title>Patient-Centered Cancer Prevention In Chinese Americans</brief_title>
  <official_title>Patient-Centered Cancer Prevention In Chinese Americans</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>NYU Langone Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute on Minority Health and Health Disparities (NIMHD)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>NYU Langone Health</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will assess the efficacy, adoption, and impact of an integrated intervention to
      improve adherence to recommended stomach cancer prevention guidelines (H. pylori
      test-and-treat) for at-risk Chinese Americans in NYC. The integrated multifaceted
      theory-based intervention involves: 1) a health systems-level intervention using electronic
      health record (EHR)-based tools to facilitate H. pylori test-and-treat strategies; and 2) a
      community-engaged culturally and linguistically adapted CHW-led patient navigation program we
      are currently pilot testing for feasibility and acceptability. Using a 2-arm randomized
      controlled trial (RCT) design, &gt; 144 Chinese American patients across NYC safety net hospital
      endoscopy clinics and primary health centers will participate.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 15, 2018</start_date>
  <completion_date type="Anticipated">November 2020</completion_date>
  <primary_completion_date type="Anticipated">November 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in H. pylori eradication</measure>
    <time_frame>2 months, 6 months</time_frame>
    <description>Measured using breath ammonia measurement, fecal stool antigen test or other clinically approved H. pylori infection diagnostic test</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Satisfaction with integrated intervention</measure>
    <time_frame>2 months, 6 months</time_frame>
    <description>Average score of satisfaction with integrated intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Acceptability of integrated intervention program</measure>
    <time_frame>2 months, 6 months</time_frame>
    <description>Measured through questions to assess acceptability of integrated intervention program</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">144</enrollment>
  <condition>Diabetes</condition>
  <arm_group>
    <arm_group_label>Health systems-level intervention</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>using electronic health record (EHR)-based tools to facilitate H. pylori test-and-treat strategies;</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CHW-led patient navigation program</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>a community-engaged culturally and linguistically adapted CHW-led patient navigation program we are currently pilot testing for feasibility and acceptability</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Test-and-treat EHR-CHW intervention</intervention_name>
    <description>a health systems-level intervention using electronic health record (EHR)-based tools to facilitate H. pylori test-and-treat strategies</description>
    <arm_group_label>Health systems-level intervention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Usual care of EHR-only intervention</intervention_name>
    <description>a community-engaged culturally and linguistically adapted CHW-led patient navigation program we are currently pilot testing for feasibility and acceptability.</description>
    <arm_group_label>CHW-led patient navigation program</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  self identifies as Chinese American

          -  is an outpatient aged 21 years and older (adult)

          -  plans to continue to live in the region during the next 12 months;

          -  is willing to be randomized to either treatment or control groups

          -  has a confirmed diagnosis of H. pylori infection by at least one of the following
             methods: C-urea breath test, histology, rapid urease test or bacterial culture, fecal
             stool antigen test or other clinically approved H. pylori infection diagnostic test.

        Exclusion Criteria:

          -  advanced chronic disease that would not allow the patient to complete follow-up or
             attend visits;

          -  allergy to any of the study drugs;

          -  pregnancy or currently breastfeeding

          -  taking antibiotics or bismuth salts within 2 weeks before the study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Simona Kwon, DrPH,MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>NYU Langone Health</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Janet Pan</last_name>
    <phone>212 263 0483</phone>
    <email>Janet.Pan@nyulangone.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>New York University School of Medicine</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Janet Pan</last_name>
      <phone>212-263-0483</phone>
      <email>janet.pan@nyumc.org</email>
    </contact>
    <investigator>
      <last_name>Simona Kwon, PhD, MPH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>November 6, 2017</study_first_submitted>
  <study_first_submitted_qc>November 8, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 13, 2017</study_first_posted>
  <last_update_submitted>November 12, 2019</last_update_submitted>
  <last_update_submitted_qc>November 12, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 13, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>H. pylori</keyword>
  <keyword>H. pylori infection</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

